Latest Breaking News On - Research development at projen - Page 1 : comparemela.com

/PRNewswire/ ProJenX, Inc., a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for.

Neil shneiderClaire henchcliffeErin flemingJoe lewcockLee rubinPhd harvard universityPhd columbia universityResearch development at projenNeuroscience programHarvard stem cell instituteColumbia universityRegenerative biology at harvard universityPrnewswire projenx incScientific advisory boardDenali therapeuticsHarvard university